Home > Compound List > Product Information
Nystatin_Molecular_structure_CAS_1400-61-9)
Click picture or here to close

Nystatin

Catalog No. DB00646 Name DrugBank
CAS Number 1400-61-9 Website http://www.ualberta.ca/
M. F. C47H75NO17 Telephone (780) 492-3111
M. W. 926.0949 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 528

SYNONYMS

IUPAC name
(21E,23E,25E,27E,31E,33E)-20-{[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy}-4,6,8,11,12,16,18,36-octahydroxy-35,37,38-trimethyl-2,14-dioxo-1-oxacyclooctatriaconta-21,23,25,27,31,33-hexaene-17-carboxylic acid
IUPAC Traditional name
nystatin
Brand Name
Nystatin-Triamcinolone Acetonide
Pedi-Dri
Nystex
Nysert
Barstatin 100
Candex
Korostatin
Mycolog-Ii
Mycostatin
Mykacet
Nadostine
Nilstat
Nyaderm
PMS Nystatin
Sodium nystatin
nystatin dihydrate
Myco-Triacet Ii
Mykinac
Mytrex F
Nystaform
Nystatin sodium
Nystatin, sodium salt
Nystop

DATABASE IDS

PubChem CID 11953884
PubChem SID 46504780
CAS Number 1400-61-9

PROPERTIES

Hydrophobicity(logP) 0.5
Solubility 360 mg/L

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Nystatin is a polyene antifungal drug to which many molds and yeasts are sensitive, including Candida spp. Nystatin has some toxicity associated with it when given intravenously, but it is not absorbed across intact skin or mucous membranes. It is considered a relatively safe drug for treating oral or gastrointestinal fungal infections.
Indication For treatment of cutaneous or mucocutaneous mycotic infections caused by Candida species
Pharmacology Nystatin is an antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi, including Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton rubrum, T. mentagrophytes. Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing levels of nystatin, Candida albicans does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of Candida (C. tropicalis, C. guilliermondi, C. krusei, and C. stellatoides) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.
Affected Organisms
Fungi
Absorption Nystatin is not absorbed from intact skin or mucous membrane.
References
Akaike N, Harata N: Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn J Physiol. 1994;44(5):433-73. [Pubmed]
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

REFERENCES

  • Akaike N, Harata N: Nystatin perforated patch recording and its applications to analyses of intracellular mechanisms. Jpn J Physiol. 1994;44(5):433-73. Pubmed